Back
Bristol Myers Squibb Co. Vs. Merck & Co., Inc. Industry Stock Comparison
Buy
76
BMY
Bristol Myers Squibb Co.
Last Price:
$54.69
Seasonality Move:
14.3%
Buy
66
MRK
Merck & Co., Inc.
Last Price:
$106.53
Seasonality Move:
0.72%
Buy
76
Bristol Myers Squibb Co. (BMY)
is a Buy
Is Bristol Myers Squibb Co. a Buy, Sell or Hold?
-
The current Bristol Myers Squibb Co. [BMY] share price is $54.71. The Score for BMY is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
BMY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Merck & Co., Inc. (MRK)
is a Buy
Is Merck & Co., Inc. a Buy, Sell or Hold?
-
The current Merck & Co., Inc. [MRK] share price is $106.45. The Score for MRK is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
MRK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMY Stock Price Chart
What is Bristol Myers Squibb Co.'s stock price today?
-
The Bristol Myers Squibb Co. share price today is $54.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
MRK Stock Price Chart
What is Merck & Co., Inc.'s stock price today?
-
The Merck & Co., Inc. share price today is $106.45Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRK is experiencing slight buying pressure.
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.83 | Buy |
| Relative Strength Index (14 RSI): | 69.72 | Buy |
| Chaikin Money Flow: | 8760555 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.26 - 53.82) | Buy |
| Bollinger Bands (100): | (44.25 - 50.19) | Buy |
MRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.56 | Buy |
| Relative Strength Index (14 RSI): | 70.33 | Buy |
| Chaikin Money Flow: | 2140408 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (97.59 - 103.81) | Buy |
| Bollinger Bands (100): | (81.19 - 96.55) | Buy |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.16 | Buy |
| 20-day SMA: | 52.07 | Buy |
| 50-day SMA: | 48.26 | Buy |
| 200-day SMA: | 48.67 | Buy |
| 8-day EMA: | 53.87 | Buy |
| 20-day EMA: | 52.18 | Buy |
| 50-day EMA: | 49.62 | Buy |
| 200-day EMA: | 48.96 | Buy |
MRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 101.96 | Buy |
| 20-day SMA: | 101.18 | Buy |
| 50-day SMA: | 94.15 | Buy |
| 200-day SMA: | 85.36 | Buy |
| 8-day EMA: | 102.9 | Buy |
| 20-day EMA: | 100.5 | Buy |
| 50-day EMA: | 95.72 | Buy |
| 200-day EMA: | 90.49 | Buy |
Bristol Myers Squibb Co. Earnings Growth & BMY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.62 per share, and a decrease next year of $0.54 per share.
Merck & Co., Inc. Earnings Growth & MRK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.36 per share, and a decrease next year of $0.68 per share.
Bristol Myers Squibb Co. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Merck & Co., Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||